| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by financing activities | 204,051 | 202,077 |
| Net increase (decrease) in cash, cash equivalents and restricted cash | 13,043 | 3,197 |
| Cash and cash equivalents at beginning of period | 38,750 | - |
| Cash and cash equivalents at end of period | 51,793 | - |
Sionna Therapeutics, Inc. (SION)
Sionna Therapeutics, Inc. (SION)